HIGHEST STRENGTH BEST SELLER – Transforme’s Glucosamine Sulphate 2KCl 1500mg tablets are among our longest standing and best selling supplements. Each super strength 1500mg Glucosamine Sulphate 2KCl tablet contains 1131mg of Glucosamine Sulphate, providing you with a potent 888MG OF PURE (BASE) GLUCOSAMINE (per tablet) – always check the label
MAXIMUM POTENCY, TOP VALUE – Our bottle contains 365 one a day tablets, giving you a full year of high quality support. We also supply 180 and 90 tablet packs
EASY TO SWALLOW – Our 1500mg tablets are coated to ease swallowing, or simply use the BREAK LINE to split them in half if you prefer smaller tablets
UK MADE – Transforme manufactures in the UK to Good Manufacturing Practice standards. Our tablets are free from salt, starch, wheat, gluten, yeast, lactose, dairy products, artificial preservatives, dyes, colours and genetically modified organisms
TREATMENT: treat and prevent frequent episodic and chronic migraines
CONTROL: 40 levels of intensity to give you complete control over your pain relief and comfort
PROGRAMMES: two distinctive programmes. One helping with prevention, one helping with treatment. Meaning you will be getting the specific pain relief you require
TECHNOLOGY: the Mynd utilises clinically proven TENS technology. Offering you safe and effective programmes with no side effect. Giving you peace of mind you’re getting the relief you need.
ANYWHERE: the unit comes with a travel case and miniature mirror, allowing you to use the Mynd and get your pain relief where ever you need it – whether it be at home, on the go or at work. The Mynd is the perfect travel companion
Simple 4 angle shaped with excellent touching feeling. Disposable for convenient and portable use.
Safe, soft, sterile and unflavored oral swabs, using for the daily oral care and household supplies, electronic industry.
Gently clean, moisten and refresh mouth, teeth and gums due to dental supplies, teeth sensitivity or disease, achieving the effect of the protection and cleaning of the oral care.
